Document is current
Any future updates will be listed below
-
Authors
DeTemple, Viola K. https://orcid.org/0000-0001-6246-8862
Walter, Antje https://orcid.org/0009-0007-5970-7755
Bredemeier, Sabine https://orcid.org/0009-0005-0950-8323
Gutzmer, Ralf https://orcid.org/0000-0001-7921-2820
Schaper-Gerhardt, Katrin https://orcid.org/0000-0002-5318-0039
-
Funding
Funding for this research was provided by:
Almirall
Ruhr-Universität Bochum
- License Information
-
More Information
Article History
Received: 25 April 2024
Revised: 25 April 2024
Accepted: 26 April 2024
First Online: 7 June 2024
Declarations
:
: Viola K. DeTemple received a research grant, honoraria for talks and travel support from SUN Pharma. Katrin Schaper-Gerhardt received a research grant from Almirall and Kyowa Kirin. Ralf Gutzmer served as consultant for BristolMyers Squibb, Roche Pharma, MerckSharpDohme, Novartis, GlaxoSmithKline, Amgen, Almirall Hermal, LEO, Pfizer, Incyte, Pierre-Fabre, Sun Pharma. Ralf Gutzmer received honoraria for lectures from BristolMyers Squibb, Roche Pharma, MerckSharpDohme, Novartis, Amgen, Merck Serono, Almirall-Hermal, Pierre-Fabre, Sanofi, SUN Pharma, Bayer. Ralf Gutzmer received travel support from BristolMyers Squibb, Merck Serono, SUN Pharma, Roche Pharma. Ralf Gutzmer received research grants from Pfizer, Novartis, Johnson&Johnson, Sanofi, Merck Serono, Amgen, SUN Pharma. The other authors declare that they have no conflict of interest.
